0 results

Patient Corner

Anatomical Illustrations

More
  • Ankylosing spondylitis

    Ankylosing spondylitis

    Read more
  • Rheumatoid polyarthritis at the initial stage

    Rheumatoid polyarthritis at the initial stage

    Read more
  • Otitis

    Otitis

    Read more
  • Arterial hypertension

    Arterial hypertension

    Read more
  • Hip - Development of osteoporosis

    Hip - Development of osteoporosis

    Read more
  • Benign hypertrophy of the prostate
transverse section of the prostate

    Benign hypertrophy of the prostate transverse section of the prostate

    Read more
  • Benign hypertrophy of prostate gland

    Benign hypertrophy of prostate gland

    Read more
  • The parietal cell

    The parietal cell

    Read more
  • Diagnosis and results obtained from the osteodensitometry test (t score)

    Diagnosis and results obtained from the osteodensitometry test (t score)

    Read more
  • Benign hypertrophy of prostate gland
(prostatic fibrosis and urethral involvement)

    Benign hypertrophy of prostate gland (prostatic fibrosis and urethral involvement)

    Read more
  • Development of hip arthritis

    Development of hip arthritis

    Read more
  • Colonic polyp

    Colonic polyp

    Read more

Last reference updates

  • Apr 21, 2017 - MedWatch Drug Updates

FDA restricts use of codeine and tramadol in children and breastfeeding women-Risk of serious adverse reactions

FDA urges do not use codeine and tramadol in children and breastfeeding women because of potential risk of serious adverse events

Read more
  • Apr 14, 2017 - MedWatch Drug Updates

Recall of Homeopathic Baby Teething products by Hyland- Elevated levels of belladonna

Recall of Homeopathic Baby Teething products due to high level of belladonna far exceeding the amount claimed on the label

Read more
  • Apr 12, 2017 - FDA Drug Updates

FDA approved Ingrezza (valbenazine) for tardive dyskinesia

Ingrezza (valbenazine) is approved as first treatment for tardive dyskinesia

Read more
  • Apr 7, 2017 - MedWatch Drug Updates

Recall of sterile products by Isomeric Pharmacy Solutions- Lack of sterility assurance

Recall of sterile products by Isomeric Pharmacy Solutions due to FDA concerns over lack of sterility assurance

Read more
  • Apr 3, 2017 - MedWatch Drug Updates

Recall of EpiPen and EpiPen Jr Auto-Injector- Failure to activate device due to defect in a supplier component

Recall of EpiPen and EpiPen Jr Auto-Injector due to defect in a supplier components which may result in failure to activate device

Read more
  • Mar 30, 2017 - FDA Drug Updates

FDA approved Ocrevus (ocrelizumab) for multiple sclerosis

Ocrevus (ocrelizumab) is approved as first treatment for primary progressive multiple sclerosis

Read more
  • Mar 29, 2017 - FDA Drug Updates

FDA approves Dupixent (dupilumab) for atopic dermatitis

FDA approved Dupixent (dupilumab) for the treatment of moderate to severe eczema

Read more
  • Mar 29, 2017 - FDA Drug Updates

FDA approved Zejula (niraparib) for recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer

Zejula (niraparib) is approved as maintenance therapy for recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer

Read more
  • Mar 24, 2017 - FDA Drug Updates

FDA approved Bavencio (avelumab) for Merkel cell carcinoma

Bavencio (avelumab) is approved as the first treatment for Merkel cell carcinoma, a rare form of skin cancer

Read more
  • Mar 22, 2017 - FDA Drug Updates

FDA approved Xadago (safinamide) for Parkinson’s disease

Xadago (safinamide) approved as an add-on therapy for the treatment of Parkinson’s disease

Read more